Kun Meng
Amministratore Delegato presso Beijing Shenogen Pharma Group Ltd.
Profilo
Kun Meng is the founder of Beijing Shenogen Pharma Group Ltd.
He has a graduate degree from Harvard University, which he received in 2000.
He also holds a doctorate degree from the University of Chinese Academy of Sciences, which he obtained in 1992.
Posizioni attive di Kun Meng
Società | Posizione | Inizio |
---|---|---|
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Amministratore Delegato | - |
Formazione di Kun Meng
University of Chinese Academy of Sciences | Doctorate Degree |
Harvard University | Graduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |
- Borsa valori
- Insiders
- Kun Meng